Pharmaceuticals, Inc. is primarily focused on development and
commercialization of innovative pharmaceutical products that treat
allergic, pulmonary, and other respiratory related diseases.
in 2008, Acton's management includes pharmaceutical executives with
decades of aerosol, chemistry, clinical development, and commercial
In 2009, Acton simultaneously completed a Series A round of financing with Sequoia Capital and the licensing of AEROSPAN®
from Forest Laboratories, Inc. (NYSE: FRX). The partnership with
Forest, a leading U.S. pharmaceutical company, gives Acton exclusive
global rights to develop and market AEROSPAN including the $7.0 billion
U.S. inhaled steroid market.
In 2011, Acton completed a licensing
agreement with Sanofi U.S. for NASACORT HFA™. The license agreement
for prescription NASACORT HFA™ provides Acton exclusive U.S. rights to
develop and market NASACORT HFA™ in the $2 billion prescription nasal
Acton Pharmaceuticals selected AEROSPAN and
NASACORT HFA as its lead products because of the commercial viability
of the products and their stage of development. Both products have
already received NDA approval by the U.S. Food and Drug Administration
(FDA) and will be launched in the United States upon completion of
additional manufacturing work and submissions to the FDA. Acton
Pharmaceuticals is leveraging its chemistry and aerosol development
expertise to enable commercial scale manufacturing of both products so
that they will be made available to the millions of asthma and allergy
sufferers in the U.S. in the near future.
With two NDA-stage
compounds that will be prescribed in distinct multi-billion dollar
markets, Acton Pharmaceuticals is poised for accelerated growth. The
Company is currently completing development of AEROSPAN® and NASACORT
HFA™ and plans to launch both products in the U.S. marketplace with its
own commercial sales force. In addition, Acton is now actively seeking
to acquire additional mid to late stage respiratory and pediatric
Acton’s corporate headquarters are located in Marlborough, MA.